AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • March 1st, 2013 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 1st, 2013 Company Industry JurisdictionThis agreement is dated December __, 2012 and is by and between HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Company,” “us,” “we” or “our”), and [Name of Officer] (“you” or “your”).
AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • March 1st, 2013 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 1st, 2013 Company Industry JurisdictionThis agreement is dated December 21, 2012 and is by and between HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Company,” “us,” “we” or “our”), and Gregory Frost (“you” or “your”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • March 1st, 2013 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 1st, 2013 Company Industry JurisdictionThis agreement is dated December __, 2012, and is by and between HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Company,” “us,” “we” or “our”), and [EXECUTIVE NAME] (“you” or “your”).